Skip to main content
. Author manuscript; available in PMC: 2014 Jan 28.
Published in final edited form as: J Clin Pharmacol. 2011 Mar 21;51(8):1186–1194. doi: 10.1177/0091270010379810

Table 2.

Comparison of Sodium 2,2 Dimethylbutyrate Administered under Fasted and Non-Fasting Conditions. Studies were performed at the 20 mg/kg dose level.

Dependent Variable Mean Frel % p-value
Fasting Nonfasting Difference
Cmax (μg/mL) 88.92 60.40 28.52 67.9 0.0037
AUC(0-last) h•μg/mL 1174 1162 12.10 99.0 0.8559
AUC (0-∞) h•μg/mL 1190 1186 3.267 99.7 0.9638
Tmax 0.750 4.50 −3.75 NC 0.0355

Abbreviations: CI: confidence interval; Frel: relative bioavailability; NC: not calculated; SD: standard deviation